Faseb Bioadvances impact factor, indexing, ranking (2024)


faseb

Aim and Scope

The Faseb Bioadvances is a research journal that publishes research related to Biochemistry, Genetics and Molecular Biology. This journal is published by the Wiley-Blackwell Publishing Ltd. The ISSN of this journal is 25739832. Based on the Scopus data, the SCImago Journal Rank (SJR) of faseb bioadvances is 0.731.

Also, please check the following important details about faseb bioadvances: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.

According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.

Faseb Bioadvances Ranking

Impact Factor: 2.5
5-Year JIF: 2.6
SJR (SCImago Journal Rank): 0.731
Quartile: Q2

The latest Impact Factor list (JCR) is released in June 2024.

The Impact Factor of Faseb Bioadvances is 2.5.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times its articles are cited.

The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI) in Philadelphia. Impact factors began to be calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson-Reuters spun off and sold ISI to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.


Important Metrics

Journal Title: FASEB BioAdvances
Publisher: Wiley-Blackwell Publishing Ltd
ISSN: 25739832
Type: journal
Journal Scope: Biochemistry, Genetics and Molecular Biology
Country: United Kingdom
H-Index: 15
SJR: 0.731
Quartile: Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Molecular Medicine (Q2); Physiology (Q2); Cancer Research (Q3)

Indexing

The faseb bioadvances is indexed in:

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).

Note: ESCI journals donot come with an impact factor. However, ESCI journals are evaluated every year and those who qualified are transferred to SCIE.


Faseb Bioadvances Impact Factor 2024

The latest impact factor of faseb bioadvances is 2.5 which is recently updated in June, 2024.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times it's articles are cited.

Note: Every year, The Clarivate releases the Journal Citation Report (JCR). The JCR provides information about academic journals including impact factor. The latest JCR was released in June, 2023. The JCR 2024 will be released in the June 2024.


Quartile

The latest Quartile of faseb bioadvances is Q2.

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.


Publication fee

According to journal website, the publication fee of faseb bioadvances is around 2500 USD; 2280 GBP; 2800 EUR.

The faseb bioadvances has also Journal waiver policy (for developing countries, authors etc).

An article processing charge (APC), also known as a publication fee, is a fee which is sometimes charged to authors. Most commonly, it is involved in making a work available as open access (OA), in either a full OA journal or in a hybrid journal.


Journal Publication Time

The Journal Publication Time means the average number of weeks between article submission and publication. According to the journal website, the faseb bioadvances publishes research articles in 10 weeks on an average.



Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Faseb Bioadvances?

If your research is related to Biochemistry, Genetics and Molecular Biology, then visit the official website of faseb bioadvances and send your manuscript.

Tips for publishing in Faseb Bioadvances:

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Alternatively, they can contact the editor of the journal.

Final Summary

  • The impact factor of faseb bioadvances is 2.5.
  • The faseb bioadvances is a reputed research journal.
  • It is published by Wiley-Blackwell Publishing Ltd.
  • The journal is indexed in UGC CARE, Scopus, ESCI, DOAJ, PubMed.
  • It is an open access journal.
  • The (SJR) SCImago Journal Rank is 0.731.
  • The publication time (Average number of weeks between article submission and publication) of the journal is 10 weeks.
  • The Publication fee (APC) of faseb bioadvances 2500 USD; 2280 GBP; 2800 EUR.

Sources: https://onlinelibrary.wiley.com/journal/25739832







SIMILIAR JOURNALS


DNA AND CELL BIOLOGY

ISSN: 1044-5498
Publisher: MARY ANN LIEBERT, INC

JOURNAL OF MOLECULAR EVOLUTION

ISSN: 0022-2844
Publisher: SPRINGER

MOLECULAR BIOLOGY AND EVOLUTION

ISSN: 0737-4038
Publisher: OXFORD UNIV PRESS

MOLECULAR PHYLOGENETICS AND EVOLUTION

ISSN: 1055-7903
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCE

ONCOGENE

ISSN: 0950-9232
Publisher: SPRINGERNATURE

MOLECULAR REPRODUCTION AND DEVELOPMENT

ISSN: 1040-452X
Publisher: WILEY

NON-CODING RNA

ISSN:
Publisher: MDPI

BIOCHEMICAL GENETICS

ISSN: 0006-2928
Publisher: SPRINGER/PLENUM PUBLISHERS

CHROMOSOMA

ISSN: 0009-5915
Publisher: SPRINGER

CHROMOSOME RESEARCH

ISSN: 0967-3849
Publisher: SPRINGER

TOP RESEARCH JOURNALS

Credit and Source: Scopus, Clarivate, UGC CARE.